SEARLE’s AMBIEN NON-BENZODIAZEPINE HYPNOTIC CLEARS FDA DEC. 16: NEW CLASS OF SEDATIVE FOR U.S. MARKET; FDA USES END-OF-YEAR LEVERAGE FOR TIGHTER INDICATION